| scholarly article | Q13442814 |
| P50 | author | John M. Luk | Q42935545 |
| P2093 | author name string | Marie C Lin | |
| Lei Chen | |||
| Philip J Day | |||
| Nikki P Lee | |||
| Stella Sun | |||
| Chun Yeung | |||
| Ronnie T Poon | |||
| Laura Beretta | |||
| Jirun Peng | |||
| Xisheng Leng | |||
| Felice H Tsang | |||
| P2860 | cites work | Kidney claudin-19: localization in distal tubules and collecting ducts and dysregulation in polycystic renal disease | Q24301628 |
| Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain | Q24553321 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients | Q28201418 | ||
| The many roles of cytochrome b5 | Q28206247 | ||
| Cathepsin B | Q28245818 | ||
| HSP27 and HSP70: potentially oncogenic apoptosis inhibitors | Q28679273 | ||
| Histological grading and staging of chronic hepatitis | Q29619625 | ||
| Progesterone receptor membrane component 1: an integrative review. | Q30157942 | ||
| Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study | Q30931175 | ||
| Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. | Q31030672 | ||
| Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma | Q31160184 | ||
| Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. | Q33221629 | ||
| Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach | Q79192633 | ||
| Increased solubility of integrin betaA domain using maltose-binding protein as a fusion tag | Q79790573 | ||
| The values and limitations of glypican-3 as a novel tumor marker for hepatocellular carcinoma from clinical and economic viewpoints | Q80428386 | ||
| Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? | Q80880009 | ||
| Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions | Q81816457 | ||
| Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis | Q33225672 | ||
| Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values | Q33231146 | ||
| Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. | Q33298434 | ||
| Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. | Q33302500 | ||
| Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma | Q33329606 | ||
| Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes | Q34115973 | ||
| Homeostasis: a scavenger receptor for haemoglobin | Q34264980 | ||
| Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. | Q34392558 | ||
| Role of haptoglobin in free hemoglobin metabolism | Q34408470 | ||
| Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors | Q34428156 | ||
| Stressed to death: regulation of apoptotic signaling pathways by the heat shock proteins | Q34467940 | ||
| The roles of cytochrome b5 in cytochrome P450 reactions | Q35025216 | ||
| Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders | Q35363234 | ||
| Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma | Q35929138 | ||
| Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions | Q36038173 | ||
| Proteomics for the early detection and treatment of hepatocellular carcinoma | Q36519019 | ||
| Intermediate filaments: a role in epithelial polarity | Q36787622 | ||
| Structural and regulatory functions of keratins. | Q36791981 | ||
| Heat shock proteins: essential proteins for apoptosis regulation | Q37081794 | ||
| Progesterone receptor membrane component 1--many tasks for a versatile protein | Q40016630 | ||
| Identification of glypican-3 as a novel tumor marker for melanoma | Q40505788 | ||
| Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. | Q40560262 | ||
| Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review | Q40864701 | ||
| Observing proteases in living cells | Q40874788 | ||
| alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma | Q41811600 | ||
| Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models | Q46693145 | ||
| Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. | Q46841235 | ||
| A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker. | Q47603877 | ||
| Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue | Q47970481 | ||
| Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma | Q47990322 | ||
| Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? | Q51815043 | ||
| Artificial neural networks and decision tree model analysis of liver cancer proteomes. | Q51910012 | ||
| Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium. | Q52017854 | ||
| Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications | Q60245921 | ||
| Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma | Q67537553 | ||
| Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis | Q73042380 | ||
| Signaling mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of tyrosine phosphorylation | Q73551294 | ||
| Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma | Q73638685 | ||
| Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort | Q74026570 | ||
| Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma | Q74261948 | ||
| P433 | issue | 3 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1293-1303 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Journal of Proteome Research | Q3186939 |
| P1476 | title | Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma | |
| P478 | volume | 8 |
| Q38114382 | Alpha-fetoprotein: a renaissance. |
| Q34933977 | An empirical assessment of validation practices for molecular classifiers |
| Q42245165 | An update on the mouse liver proteome |
| Q34988368 | Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma |
| Q41128802 | Can proteomics lead to the discovery of real biomarkers for HCC? |
| Q36420885 | Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma. |
| Q28289016 | Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients |
| Q35158630 | Comparative study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's disease |
| Q35627178 | Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage |
| Q28242740 | DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival |
| Q39411411 | Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma |
| Q39619016 | Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. |
| Q37810154 | Industrialized MS-based proteomics in the search for circulating biomarkers |
| Q36414502 | Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion |
| Q57794656 | Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis |
| Q37668003 | Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection. |
| Q39572850 | Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction |
| Q35106868 | Over-expressed Testis-specific Protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma |
| Q54251377 | Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma. |
| Q39442425 | Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma. |
| Q51888547 | Proteomic analysis of differentially expressed proteins between stenotic and normal colon segment tissues derived from patients with Hirschsprung's disease. |
| Q33498165 | Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues |
| Q91870122 | Proteomic profiling in liver cancer: another new page |
| Q39060093 | Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma |
| Q36167811 | Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum |
| Q37153412 | Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study |
| Q28660980 | The Role of Mass Spectrometry in the "Omics" Era |
| Q33936575 | The application of SELDI-TOF-MS in clinical diagnosis of cancers |
| Q46255404 | Variety and Dynamics of Proteoforms in the Human Proteome: Aspects of Markers for Hepatocellular Carcinoma |
| Q92627364 | iTRAQ-based Comparative Serum Proteomic Analysis of Prostate Cancer Patients with or without Bone Metastasis |
| Q24595141 | microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma |
Search more.